obesity

FDA says Novo Nordisk’s obesity pill TV ad includes misleading claims

Read more

Novo Nordisk sues Hims & Hers over compounded obesity drugs

Read more

Eli Lilly CEO David Ricks talks Medicare coverage of obesity pills

Read more

Novo Nordisk shares rise after Wegovy obesity pill launch

Read more

2026 is the year of obesity pills from Novo Nordisk, Eli Lilly

Read more

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

Read more

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

Read more

Trump deals with Lilly, Novo Nordisk could broaden obesity drug access

Read more

Trump, Eli Lilly, Novo Nordisk unveil deals to cut obesity drug prices

Read more

Wegovy, Ozempic maker Novo Nordisk Q3 earnings

Read more